AusperBio
PrivateLast Round
Series B
Extension
Sep 21, 2025
Total Funding Raised
$236.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AusperBio is a biopharmaceutical company that develops targeted oligonucleotide therapeutics for the treatment of chronic hepatitis B and other liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AusperBio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
AusperBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 21, 2025 | ||||
| Series B Extension | May 28, 2025 | ||||
| Series B | Dec 26, 2024 | ||||
| Series A | Jul 14, 2024 | ||||
| Seed | Nov 7, 2023 |
AusperBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series B Extension, Series B |
| Genesis Capital | Series B Extension |
| YuanBio Venture Capital | Series B Extension, Series B, Series A |
| Genesis Capital | Series B Extension, Series A |
| Sherpa Capital | Series B Extension, Series B |
| Sherpa Capital | Series B Extension, Series B |
| Hankang Capital | Series B Extension, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors grew 71% MoM, from 780 to 1.3K.
- Nov 8, 2025
Presented data at the AASLD 2025 conference.
AusperBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AusperBio's valuation, stock price, and market status.